劉 秉彥

Medicine & Life Sciences

1. Acute Coronary Syndrome 49%
2. Cardiology 40%
3. Atrial Fibrillation 35%
4. Cardiac Myocytes 35%
5. Hydroxymethylglutaryl-CoA Reductase Inhibitors 31%
6. Myocardial Infarction 30%
7. Cardiovascular Diseases 30%
8. Coronary Artery Disease 28%
9. Sarcopenia 25%
10. Hypertension 24%
11. Prasugrel Hydrochloride 23%
12. Guidelines 22%
13. Inflammation 22%
14. Therapeutics 21%
15. Thrombomodulin 21%
16. Lipids 20%
17. Elderly 19%
18. Safety 19%
19. Confidence Intervals 18%
20. Thrombosis 18%
21. Neointima 18%
22. Cilostazol 17%
23. Mortality 17%
24. Hypertrophic Cardiomyopathy 17%
25. Heart 17%
26. Atherosclerosis 17%
27. Echocardiography 16%
28. Smoking 15%
29. Hospital Mortality 15%
30. LDL Cholesterol 14%
31. Anticoagulants 14%
32. gastrodin 14%
33. Atorvastatin 13%
34. Stents 13%
35. Blood Platelets 13%
36. Genes 13%
37. Protein Kinases 13%
38. Odds Ratio 13%
39. Endothelial Progenitor Cells 13%
40. Randomized Controlled Trials 12%